BLOOD REVIEWS

简称 BLOOD REV ·ENGLAND ·出版周期 Bimonthly ·年均收录 48 篇

5.7

最新影响因子

0.80%

自引率

较难

投稿难度

约稿?周期不定

审稿周期

期刊简介

BLOOD REVIEWS是一本国际知名的血液学领域期刊，ISSN号为0268-960X，由英国出版商Elsevier出版，出版地为英国，出版周期为季刊。该期刊的影响因子较高，属于SCI收录期刊，在中科院分区中通常位于医学领域的较高分区（如1区或2区）。BLOOD REVIEWS并非开放获取（OA）期刊。该杂志主要发表血液学领域的综述文章，涵盖血液疾病的发病机制、诊断、治疗及最新研究进展，内容涉及白血病、淋巴瘤、止血与血栓、输血医学等方向。其发文特点是注重高质量、权威性的综述，为临床医生和研究人员提供前沿的学术参考。杂志的质量较高，审稿严格，但因侧重综述类文章，原创性研究较少，可能存在引用周期较长的风险。总体而言，BLOOD REVIEWS是血液学领域的重要期刊，具有较高的学术影响力。

影响因子趋势

近期发表

Sequencing CD19-targeted therapies in patients with relapsed/refractory large B-cell lymphoma: A narrative review 2026-09-04

Non-transfusion-dependent β-thalassemia: A disease of clinical paradoxes 2026-08-28

Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data 2026-09-01

Targeting the hepcidin–ferroportin axis in polycythemia vera: a complementary approach to clone-directed therapies 2026-08-26

Advances in differentiation syndrome in acute promyelocytic leukemia: From mechanisms to management 2026-08-26

What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapy 2026-07-01

The Lebanese national patient blood management guidelines: A new page in the medical practice 2026-06-06

PRISMA-based systematic review on iron stores in repeat blood donors. 2026-06-23

Dysbiosis and immunothrombosis – How platelets and the gut microbiome interact 2026-04-24

Environmental exposures and multiple myeloma risk: A contemporary review of epidemiologic associations and mechanistic plausibility 2026-04-18